BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasashima S, Kawashima A, Kasashima F, Endo M, Matsumoto Y, Kawakami K. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessels 2018;33:1471-81. [DOI: 10.1007/s00380-018-1203-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Ashihara N, Ota M, Fujinaga Y, Ozawa M, Kuraishi Y, Watanabe T, Hamano H, Joshita S, Kawa S, Umemura T. The levels of IL-1β and soluble IL-1 receptors in patients with IgG4-related periaortitis/periarteritis. Adv Med Sci 2022;67:257-61. [PMID: 35785599 DOI: 10.1016/j.advms.2022.06.003] [Reference Citation Analysis]
2 Martín-Nares E, Baenas DF, Cuellar Gutiérrez MC, Hernández-Molina G, Ortiz AC, Neira O, Gutiérrez MA, Calvo R, Saad EJ, Elgueta Pinochet S, Gallo J, Herrera Moya A, Mansilla Aravena BA, Crespo Espíndola ME, Cairoli E, Bertoli AM, Córdoba M, Wurmann Kiblisky P, Basualdo Arancibia WJ, Badilla Piñeiro MN, Gobbi CA, Berbotto GA, Pisoni CN, Juárez V, Cosatti MA, Aste NM, Airoldi C, Llanos C, Vergara Melian CF, Erlij Opazo D, Goecke A, Pastenes Montaño PA, Tate P, Pirola JP, Stange Núñez L, Burgos PI, Mezzano Robinson MV, Michalland H S, Silva Labra F, Labarca Solar CH, Lencina MV, Izquierdo Loaiza JH, Del Castillo Gil DJ, Caeiro F, Paira S. Clinical and Serological Features in Latin American IgG4-Related Disease Patients Differ According to Sex, Ethnicity, and Clinical Phenotype. J Clin Rheumatol 2022. [PMID: 35612589 DOI: 10.1097/RHU.0000000000001858] [Reference Citation Analysis]
3 Łoń I, Lewandowski J, Wieliczko M, Małyszko J. Retroperitoneal fibrosis, a rare entity with urorenal and vascular subtypes - preliminary data. Ren Fail 2022;44:688-92. [PMID: 35440292 DOI: 10.1080/0886022X.2022.2064303] [Reference Citation Analysis]
4 Mizushima I, Kawano M. Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges. Int J Nephrol Renovasc Dis 2021;14:279-89. [PMID: 34349543 DOI: 10.2147/IJNRD.S239160] [Reference Citation Analysis]
5 Wang K, Wang Z, Zeng Q, Zhu L, Gao J, Wang Z, Zhang S, Yang F, Shen D, Wang Y, Liu Y. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS One 2021;16:e0245601. [PMID: 33600452 DOI: 10.1371/journal.pone.0245601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shakir A, Wheeler Y, Krishnaswamy G. The enigmatic immunoglobulin G4-related disease and its varied cardiovascular manifestations. Heart 2021;107:790-8. [PMID: 33468575 DOI: 10.1136/heartjnl-2020-318041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tsubota K, Usui Y, Nemoto R, Goto H. Identification of Markers Predicting Clinical Course in Patients with IgG4-Related Ophthalmic Disease by Unbiased Clustering Analysis. J Clin Med 2020;9:E4084. [PMID: 33348892 DOI: 10.3390/jcm9124084] [Reference Citation Analysis]
8 Yoo BW, Lee SW, Song JJ, Park YB, Jung SM. Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: a single-center retrospective study. Clin Rheumatol 2021;40:1423-30. [PMID: 32857276 DOI: 10.1007/s10067-020-05366-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067. [PMID: 32546500 DOI: 10.1136/bmj.m1067] [Cited by in Crossref: 28] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
10 Peng L, Zhang P, Li J, Liu Z, Lu H, Zhu L, Wang X, Teng F, Li X, Guo H, Fei Y, Zhang W, Zhao Y, Zeng X, Zhang F. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Res Ther 2020;22:103. [PMID: 32366271 DOI: 10.1186/s13075-020-02197-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
11 Dällenbach J, Moi L, Humair G, Letovanec I, Perreau M, Cherix S, Comte D, Vaucher J. A case report on the cytokine signature profile of immunoglobulin G4-related disease. Scand J Rheumatol 2020;49:332-3. [PMID: 32301653 DOI: 10.1080/03009742.2020.1711964] [Reference Citation Analysis]
12 Bavli Y, Chen BM, Roffler SR, Dobrovolskaia MA, Elnekave E, Ash S, Barenholz Y, Turjeman K. PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies. Molecules 2020;25:E558. [PMID: 32012928 DOI: 10.3390/molecules25030558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tsukuda S, Ikeura T, Ito T, Nakamaru K, Masuda M, Hori Y, Ikemune M, Yanagawa M, Tanaka T, Tomiyama T, Yamaguchi T, Ando Y, Uchida K, Fukui T, Nishio A, Terasawa R, Tanigawa N, Okazaki K. Clinical implications of elevated serum interleukin-6 in IgG4-related disease. PLoS One. 2020;15:e0227479. [PMID: 31951598 DOI: 10.1371/journal.pone.0227479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang W, Stone JH. Management of IgG4-related disease. The Lancet Rheumatology 2019;1:e55-65. [DOI: 10.1016/s2665-9913(19)30017-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
15 Akiyama M, Kaneko Y, Takeuchi T. Characteristics and prognosis of IgG4-related periaortitis/periarteritis: A systematic literature review. Autoimmun Rev 2019;18:102354. [PMID: 31323364 DOI: 10.1016/j.autrev.2019.102354] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
16 Tang J, Cai S, Ye C, Dong L. Biomarkers in IgG4-related disease: A systematic review. Semin Arthritis Rheum. 2020;50:354-359. [PMID: 31280934 DOI: 10.1016/j.semarthrit.2019.06.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]